首页> 外文期刊>Clinical cancer research: an official journal of the American Association for Cancer Research >Epigenetic Silencing of MicroRNA-34b/c Plays an Important Role in the Pathogenesis of Malignant Pleural Mesothelioma.
【24h】

Epigenetic Silencing of MicroRNA-34b/c Plays an Important Role in the Pathogenesis of Malignant Pleural Mesothelioma.

机译:MicroRNA-34b / c的表观遗传沉默在恶性胸膜间皮瘤的发病机理中起着重要作用。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

PURPOSE: Malignant pleural mesothelioma (MPM) is an aggressive tumor with a dismal prognosis. Unlike other malignancies, TP53 mutations are rare in MPM. Recent studies have showed that altered expression of microRNA (miRNA) is observed in human malignant tumors. In this study, we investigated the alterations of miR-34s, a direct transcriptional target of TP53, and the role of miR-34s on the pathogenesis of MPM. EXPERIMENTAL DESIGN: Aberrant methylation and expression of miR-34s were examined in MPM cell lines and tumors. miR-34b/c was transfected to MPM cells to estimate the protein expression, cell proliferation, invasion, and cell cycle. RESULTS: Aberrant methylation was present in 2 (33.3%) of 6 MPM cell lines and 13 (27.7%) of 47 tumors in miR-34a and in all 6 MPM cell lines (100%) and 40 (85.1%) of 47 tumors in miR-34b/c. Expression of miR-34a and 34b/c in all methylated cell lines was reduced and restored with 5-aza-2'-deoxycytidine treatment. Because epigenetic silencing was the major event in miR-34b/c, we investigated the functional role of miR-34b/c in MPM. miR-34b/c-transfected MPM cells with physiologic miR-34b/c expression exhibited antiproliferation with G(1) cell cycle arrest and suppression of migration, invasion, and motility. The forced overexpression of miR-34b/c, but not p53, showed a significant antitumor effect with the induction of apoptosis in MPM cells. CONCLUSIONS: We show that the epigenetic silencing of miR-34b/c by methylation is a crucial alteration and plays an important role in the tumorigenesis of MPM, suggesting potential therapeutic options for MPM. Clin Cancer Res; 17(15); 4965-74. (c)2011 AACR.
机译:目的:恶性胸膜间皮瘤(MPM)是一种侵袭性肿瘤,预后不良。与其他恶性肿瘤不同,TP53突变在MPM中很少见。最近的研究表明,在人类恶性肿瘤中观察到microRNA(miRNA)表达的改变。在这项研究中,我们调查了miR-34s(TP53的直接转录靶标)的变化以及miR-34s在MPM发病机理中的作用。实验设计:在MPM细胞系和肿瘤中检查异常甲基化和miR-34s的表达。将miR-34b / c转染至MPM细胞,以评估蛋白质表达,细胞增殖,侵袭和细胞周期。结果:miR-34a中的6个MPM细胞系中有2个(33.3%)和47个肿瘤中的13个(27.7%)存在异常,所有47个MPM细胞系中的6个(100%)和40个(85.1%)中存在异常甲基化在miR-34b / c中。在所有甲基化细胞系中,miR-34a和34b / c的表达均降低并通过5-氮杂2'-脱氧胞苷处理得以恢复。由于表观遗传沉默是miR-34b / c中的主要事件,因此我们研究了miR-34b / c在MPM中的功能。具有生理miR-34b / c表达的miR-34b / c转染的MPM细胞表现出具有G(1)细胞周期停滞和抑制迁移,侵袭和运动性的抗增殖作用。 miR-34b / c(而非p53)的强制过度表达在诱导MPM细胞凋亡方面显示出显着的抗肿瘤作用。结论:我们表明,miR-34b / c通过甲基化的表观遗传沉默是一个至关重要的改变,并且在MPM的肿瘤发生中起着重要作用,表明MPM的潜在治疗选择。临床癌症研究; 17(15); 4965-74。 (c)2011年美国机修协会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号